dactinomycin has been researched along with pd 123319 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chua, BH; Chua, CC; Hamdy, RC | 2 |
| Hibi, K; Ishigami, T; Ishii, M; Kihara, M; Nyui, N; Tamura, K; Toya, Y; Umemura, S | 1 |
| Anand-Srivastava, MB; Li, Y | 1 |
| Guo, QL; Song, ZB; Wu, H; Yan, JQ; Yang, Y | 1 |
5 other study(ies) available for dactinomycin and pd 123319
| Article | Year |
|---|---|
Regulation of thrombospondin-1 production by angiotensin II in rat heart endothelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blotting, Northern; Cell Line; Cycloheximide; Dactinomycin; Endothelium; Enzyme Inhibitors; Gene Expression Regulation; Imidazoles; Losartan; Membrane Glycoproteins; Myocardium; Protein Kinase C; Pyridines; Rats; Tetrazoles; Thrombospondins | 1997 |
Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Antihypertensive Agents; Blotting, Northern; Cattle; Culture Media, Conditioned; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; Immunoblotting; Losartan; Lymphokines; Nucleic Acid Synthesis Inhibitors; Protein Kinase C; Protein Synthesis Inhibitors; Pyridines; Rats; RNA, Messenger; Transcription Factors; Transcriptional Activation; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasoconstrictor Agents | 1998 |
Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Animals, Newborn; Benzimidazoles; beta-Galactosidase; Biphenyl Compounds; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Cycloheximide; Dactinomycin; Gene Expression Regulation; Heart; Heart Ventricles; Imidazoles; Liver; Lung; Myocardium; Promoter Regions, Genetic; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Recombinant Fusion Proteins; RNA, Messenger; RNA, Ribosomal, 18S; Stress, Mechanical; Tetrazoles; Transcription, Genetic; Transfection | 1998 |
Implication of multiple signaling pathways in the regulation of angiotensin II induced enhanced expression of Giα proteins in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bucladesine; Calcium; Cell Line; Chelating Agents; Dactinomycin; Drug Interactions; Egtazic Acid; Estrenes; Gallic Acid; Gene Expression Regulation; Genistein; GTP-Binding Protein alpha Subunits, Gi-Go; Imidazoles; Losartan; Nucleic Acid Synthesis Inhibitors; Protein Kinase Inhibitors; Pyridines; Pyrrolidinones; Rats; Signal Transduction; Type C Phospholipases | 2012 |
Tumor necrosis factor-α inhibits angiotensin II receptor type 1 expression in dorsal root ganglion neurons via β-catenin signaling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; beta Catenin; Chromans; Dactinomycin; Dose-Response Relationship, Drug; Ganglia, Spinal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Imidazoles; Indoles; Male; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Quinazolines; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha | 2013 |